Feed aggregator

Registry Data: Lemtrada More Effective than Competing MS Tx

Headlines from MedPage Today® - Sat, 09/17/2016 - 3:45pm
(MedPage Today) -- Better than fingolimod or interferon; comparable to natalizumab

PodMed: A Medical News Roundup From Johns Hopkins (with audio)

Headlines from MedPage Today® - Sat, 09/17/2016 - 2:00pm
(MedPage Today) -- This week's topics include long term results in low-risk prostate cancer, ovarian cancer screening, statin benefits, and sex differences in myocardial infarction (MI).

PodMed: A Medical News Roundup From Johns Hopkins (with audio)

Headlines from MedPage Today® - Sat, 09/17/2016 - 2:00pm
(MedPage Today) -- This week's topics include long term results in low-risk prostate cancer, ovarian cancer screening, statin benefits, and sex differences in myocardial infarction (MI).

Low Vitamin D Linked with All-Cause Death

Headlines from MedPage Today® - Sat, 09/17/2016 - 12:10pm
(MedPage Today) -- There was a significant interaction by race, with greater risks for whites

Low Vitamin D Linked with All-Cause Death

Headlines from MedPage Today® - Sat, 09/17/2016 - 12:10pm
(MedPage Today) -- There was a significant interaction by race, with greater risks for whites

D.C. Week: Clinton, Trump Release More Health Info

Headlines from MedPage Today® - Sat, 09/17/2016 - 12:00pm
(MedPage Today) -- Also, FDA considers rules for pediatric opioid trials

D.C. Week: Clinton, Trump Release More Health Info

Headlines from MedPage Today® - Sat, 09/17/2016 - 12:00pm
(MedPage Today) -- Also, FDA considers rules for pediatric opioid trials

The Truth about the 5-Second Rule: That's Improbable!

Headlines from MedPage Today® - Sat, 09/17/2016 - 10:00am
(MedPage Today) -- Also, uncovering a global tongue

The Truth about the 5-Second Rule: That's Improbable!

Headlines from MedPage Today® - Sat, 09/17/2016 - 10:00am
(MedPage Today) -- Also, uncovering a global tongue

New Ampyra Trial Bolsters MS Efficacy Claims

Headlines from MedPage Today® - Sat, 09/17/2016 - 8:43am
(MedPage Today) -- Walking ability, as reported by patients, significantly improved

New Ampyra Trial Bolsters MS Efficacy Claims

Headlines from MedPage Today® - Sat, 09/17/2016 - 8:43am
(MedPage Today) -- Walking ability, as reported by patients, significantly improved

Fluoxetine Flops as Progressive MS Therapy

Headlines from MedPage Today® - Sat, 09/17/2016 - 7:47am
(MedPage Today) -- Trial may have been underpowered to detect a benefit

Fluoxetine Flops as Progressive MS Therapy

Headlines from MedPage Today® - Sat, 09/17/2016 - 7:47am
(MedPage Today) -- Trial may have been underpowered to detect a benefit

Siponimod May Slow Worsening in SPMS

Headlines from MedPage Today® - Sat, 09/17/2016 - 7:17am
(MedPage Today) -- EXPAND study shows 21% reduction in 3-month confirmed disability progression

Siponimod May Slow Worsening in SPMS

Headlines from MedPage Today® - Sat, 09/17/2016 - 7:17am
(MedPage Today) -- EXPAND study shows 21% reduction in 3-month confirmed disability progression

Why Millennials Are Key to the Future of Healthcare

Headlines from MedPage Today® - Fri, 09/16/2016 - 6:00pm
(MedPage Today) -- Must reads about the latest news and trends in healthcare careers

Why Millennials Are Key to the Future of Healthcare

Headlines from MedPage Today® - Fri, 09/16/2016 - 6:00pm
(MedPage Today) -- Must reads about the latest news and trends in healthcare careers

More Data Needed on Opioid Use in Kids, FDA Panel Says

Headlines from MedPage Today® - Fri, 09/16/2016 - 5:13pm
(MedPage Today) -- Pediatric clinical trials urged to help fill research gaps

More Data Needed on Opioid Use in Kids, FDA Panel Says

Headlines from MedPage Today® - Fri, 09/16/2016 - 5:13pm
(MedPage Today) -- Pediatric clinical trials urged to help fill research gaps

Think More Broadly About APMs, Panel Urges

Headlines from MedPage Today® - Fri, 09/16/2016 - 5:06pm
(MedPage Today) -- Alternative payment models don't have to just be about bundles and episodes
Syndicate content